Joseph DeVivo serves as President and Chief Executive Officer of Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming medical imaging with its revolutionary handheld, whole-body ultrasound-on-a-chip technology. With over 25 years of experience in the medical technology industry, DeVivo joined Butterfly in 2020 as President and Chief Operating Officer before ascending to CEO in 2021. His leadership has been instrumental in advancing the company's mission to democratize ultrasound, making high-quality imaging accessible to clinicians worldwide through innovative products like the Butterfly iQ+ and iQ3 systems. Prior to Butterfly, DeVivo held senior executive roles at Medtronic, the world's largest medical device company, where he most recently served as President of the Cervical business within the Spine division. He also led global franchises in neuromodulation and biologics, driving significant revenue growth and market expansion. Earlier in his career, he held leadership positions at Integra LifeSciences and Johnson & Johnson, honing his expertise in product commercialization, strategic partnerships, and operational excellence across orthopedics, neurosurgery, and regenerative medicine. Under DeVivo's stewardship, Butterfly has achieved key milestones, including FDA clearances for next-generation devices, expansion into over 20 countries, and strategic collaborations with major healthcare systems and tech giants like Google Cloud. His focus on innovation, financial discipline, and scalability has positioned Butterfly as a leader in point-of-care ultrasound, improving patient outcomes and reducing healthcare costs globally. DeVivo holds a B.S. in Mechanical Engineering from Lafayette College and an MBA from the University of Rochester's Simon Business School.